Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GLUCOSE-MGH: Genetic Links Understood Through Challenge With Oral Semaglutide Exposure at MGH

NCT06003153 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT06003153
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06003153 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GLUCOSE-MGH: Genetic Links Understood Through Challenge With Oral Semaglutide Exposure at MGH
Lead sponsor
Massachusetts General Hospital
Phase
Phase 4
Overall status
Recruiting
Start date
March 12, 2024
Completion date
May 31, 2027
Enrollment
125 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

genetic predisposition, metabolic diseases, type 2 diabetes